 patients with mutations affecting human Nalcn gene expression or protein structure. This study provides insight into mechanisms underlying neuronal pacemaking as well as potential therapeutic targets against diseases associated with abnormal pacemaker properties such Parkinson's disease. ▃ ▃ ▃ Editorial note: For more information see page 1 0 2 7 on pages 9 8 6 – 5. < / FREETEXT > < / ABSTRACT > ▃